Aussie Scientists Report First Vaccine For Rheumatic Fever
This article was originally published in PharmAsia News
Executive Summary
Australian researchers report creating the first vaccine for rheumatic fever, with human trials expected to begin next year. The Queensland Institute of Medical Research scientists said animal studies have shown the vaccine to be effective in blocking the disease, caused by the streptococcus A bacteria also responsible for strep throat and rheumatic heart disease. Australia has the largest rates of rheumatic fever and heart disease infections. (Click here for more
You may also be interested in...
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.